Barzaga Arencibia Z, Choonara I. Balancing the risks and benefits of the use of over-the-counter pain medications in children. Drug Saf 2012;35(12):1119–25. https://www.ncbi.nlm.nih.gov/pubmed/23078168
Sjoukes A, Venekamp RP, van de Pol AC, Hay AD, Little P, Schilder AG Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children. Cochrane Database Syst Rev 2016;12:CD011534. https://www.ncbi.nlm.nih.gov/pubmed/27977844
Sobel RE, Lovell DJ, Brunner HI, Weiss JE, Morris PW, Gottlieb BS Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry. Pediatr Rheumatol Online J 2014;12:29. https://www.ncbi.nlm.nih.gov/pubmed/25057265
The Sydney Children’s Hospitals Network (SCHN) Policy PaGC. Pain management - The Children's Hospital at Westmead: practice guideline [2006-8215 v15]. Sydney: SCHN; 2019. https://www.schn.health.nsw.gov.au/policies
Titchen T, Cranswick N, Beggs S. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital. Br J Clin Pharmacol 2005;59(6):718–23. https://www.ncbi.nlm.nih.gov/pubmed/15948937
Turner S, Ford V. Role of the selective cyclo-oxygenase-2 (COX-2) inhibitors in children. Arch Dis Child 2004;89(2):ep46. https://ep.bmj.com/content/89/2
Wafin F, Valindas E, Wuolijoki E. Comparison of diclofenac and indomethacin suppositories in rheumatoid arthritis. Clin Rheumatol 1984;3(1):67–70. https://www.ncbi.nlm.nih.gov/pubmed/6380897
Yue Z, Jiang P, Sun H, Wu J. Association between an excess risk of acute kidney injury and concomitant use of ibuprofen and acetaminophen in children, retrospective analysis of a spontaneous reporting system. Eur J Clin Pharmacol 2014;70(4):479–82. https://www.ncbi.nlm.nih.gov/pubmed/24445686